The France Foundation

 

The France Foundation
T

Biomarker-Driven Treatment of mCRC: 65 y/o Woman With Newly Diagnosed Left Sided Disease

By The France Foundation FEATURING Timothy Cannon, Philip Philip
By The France Foundation FEATURING Timothy Cannon, Philip Philip
77 views
October 19, 2023
0 Comments
Login to view comments. Click here to Login
Oncology & Hematology
14:54
The France Foundation

Exploring the Role of Natural Anticoagulants

Feat. A. Boban
15:28
The France Foundation

Tipping the Scales: The Role of Rebalancing Agents in Achieving Hemo…

Feat. V. Jimenez-Yuste
17:12
The France Foundation

Novel Hemostasis Rebalancing Agents: Implications for the Present an…

Feat. C. Escuriola
19:39
The France Foundation

Systemic Treatment Landscape for Advanced HCC: Case Discussion - 40 …

Feat. A. Burgoyne, S. Stein
19:11
The France Foundation

Systemic Treatment Landscape for Advanced HCC: Dual Immune Checkpoin…

Feat. A. Burgoyne, S. Stein
52:18
The France Foundation

Immune Checkpoint Inhibitors & RCC: Where Are We Now?

Feat. P. Barata, T. Zhang, K. Virdee
28:59
The France Foundation

Evolving Options for the Treatment of HCC With IO and Liver-Directed…

Feat. A. Smolock, B. George
67:23
The France Foundation

Combining Locoregional and Systemic Therapy for Challenging HCC Cases

Feat. R. Avritscher, A. O. Kaseb
22:14
The France Foundation

Biomarker-Driven Treatment of mCRC: 65 y/o Woman With Newly Diagnose…

Feat. T. Cannon, P. Philip
22:34
The France Foundation

Biomarker-Driven Treatment of mCRC: 72 y/o Man With Newly Diagnosed …

Feat. T. Cannon, P. Philip
75:57
The France Foundation

Strategies for Assessing and Managing DOAC-Related Bleeding

Feat. D. Siegal, A. (Ander) Cohen
17:54
The France Foundation

Finding the Balance in Natural Anticoagulants: Implications for the …

Feat. C. Escuriola
14:54
The France Foundation

The Role of Natural Anticoagulants: The Balancing Act - What Do We K…

Feat. A. Boban